Affiner la recherche

  • Livres (17)

  • Neuf (17)

à

Fourchette de prix personnalisée (EUR)

à

Andy divya (17 résultats)

  • Langue : anglais

    Edité par Igi Global Scientific Publishing, 2026

    9798260001622

    • Couverture souple

    Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 253,19

    EUR 2,72 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • Langue : anglais

    Edité par Igi Global Scientific Publishing, 2026

    9798260001615

    • Couverture rigide

    Vendeur : California Books, Miami, FL, Etats-UnisCalifornia Books

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 299,90

    EUR 2,72 expédition 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    Etat : New.

  • Langue : anglais

    Edité par IGI GLOBAL SCIENTIFIC PUBLISHING, 2026

    9798260001615

    • Couverture rigide

    Vendeur : Home-set, Mannheim, AllemagneHome-set

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 372,25

    EUR 60,98 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponibles

    Gebundene Ausgabe. Etat : Neu. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. Sprache: Englisch Gewicht in Gramm: 1119.…

  • Langue : anglais

    Edité par IGI GLOBAL SCIENTIFIC PUBLISHING, 2026

    9798260001622

    • Couverture souple
    • impression à la demande

    Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-UniPBShop.store UK

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 207,54

    EUR 7,04 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    PAP. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Langue : anglais

    Edité par IGI GLOBAL SCIENTIFIC PUBLISHING, 2026

    9798260001622

    • Couverture souple
    • impression à la demande

    Vendeur : PBShop.store US, Wood Dale, IL, Etats-UnisPBShop.store US

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 219,17

     Frais de port gratuits 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    PAP. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Langue : anglais

    Edité par Igi Global Scientific Publishing, 2026

    9798260001622

    • Couverture souple
    • impression à la demande

    Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-UnisGrand Eagle Retail

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 254,13

     Frais de port gratuits 
    Expédition nationale : Etats-Unis

    Quantité disponible : 1 disponible

    Paperback. Etat : new. Paperback. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Langue : anglais

    Edité par IGI GLOBAL SCIENTIFIC PUBLISHING, 2026

    9798260001615

    • Couverture rigide
    • impression à la demande

    Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-UniPBShop.store UK

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 245,22

    EUR 8,10 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    HRD. Etat : New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Langue : anglais

    Edité par IGI GLOBAL SCIENTIFIC PUBLISHING, 2026

    9798260001615

    • Couverture rigide
    • impression à la demande

    Vendeur : PBShop.store US, Wood Dale, IL, Etats-UnisPBShop.store US

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 259,21

     Frais de port gratuits 
    Expédition nationale : Etats-Unis

    Quantité disponible : Plus de 20 disponibles

    HRD. Etat : New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

  • Langue : anglais

    Edité par Igi Global Scientific Publishing, 2026

    9798260001622

    • Couverture souple
    • impression à la demande

    Vendeur : CitiRetail, Stevenage, Royaume-UniCitiRetail

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 217,91

    EUR 44,35 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 1 disponible

    Paperback. Etat : new. Paperback. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

  • Langue : anglais

    Edité par Igi Global Scientific Publishing, 2026

    9798260001615

    • Couverture rigide
    • impression à la demande

    Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-UnisGrand Eagle Retail

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 296,80

     Frais de port gratuits 
    Expédition nationale : Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. Etat : new. Hardcover. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

  • Langue : anglais

    Edité par Igi Global Scientific Publishing, 2026

    9798260001615

    • Couverture rigide
    • impression à la demande

    Vendeur : CitiRetail, Stevenage, Royaume-UniCitiRetail

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 256,81

    EUR 44,35 expédition 
    Expédition depuis Royaume-Uni vers Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. Etat : new. Hardcover. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.…

  • Langue : anglais

    Edité par Igi Global Scientific Publishing, 2026

    9798260001622

    • Couverture souple
    • impression à la demande

    Vendeur : AussieBookSeller, Truganina, VIC, AustralieAussieBookSeller

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 281,59

    EUR 33,56 expédition 
    Expédition depuis Australie vers Etats-Unis

    Quantité disponible : 1 disponible

    Paperback. Etat : new. Paperback. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Langue : anglais

    Edité par IGI GLOBAL SCIENTIFIC PUBLISHING, 2026

    9798260001622

    • Couverture souple
    • impression à la demande

    Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 294,43

    EUR 35,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponibles

    Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more.…

  • Langue : anglais

    Edité par IGI GLOBAL SCIENTIFIC PUBLISHING, 2026

    9798260001622

    • Couverture souple
    • impression à la demande

    Vendeur : preigu, Osnabrück, Allemagnepreigu

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 275,60

    EUR 70,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 5 disponibles

    Taschenbuch. Etat : Neu. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies | Divya Andy (u. a.) | Taschenbuch | Englisch | 2026 | IGI GLOBAL SCIENTIFIC PUBLISHING | EAN 9798260001622 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand. …

  • Langue : anglais

    Edité par Igi Global Scientific Publishing, 2026

    9798260001615

    • Couverture rigide
    • impression à la demande

    Vendeur : AussieBookSeller, Truganina, VIC, AustralieAussieBookSeller

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 329,25

    EUR 33,56 expédition 
    Expédition depuis Australie vers Etats-Unis

    Quantité disponible : 1 disponible

    Hardcover. Etat : new. Hardcover. Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more. This item is printed on demand. Shipping may be from our Sydney, NSW warehouse or from our UK or US warehouse, depending on stock availability.…

  • Langue : anglais

    Edité par IGI GLOBAL SCIENTIFIC PUBLISHING, 2026

    9798260001615

    • Couverture rigide
    • impression à la demande

    Vendeur : preigu, Osnabrück, Allemagnepreigu

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 317,35

    EUR 70,00 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 5 disponibles

    Buch. Etat : Neu. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies | Divya Andy (u. a.) | Buch | Englisch | 2026 | IGI GLOBAL SCIENTIFIC PUBLISHING | EAN 9798260001615 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.…

  • Langue : anglais

    Edité par IGI GLOBAL SCIENTIFIC PUBLISHING, 2026

    9798260001615

    • Couverture rigide
    • impression à la demande

    Vendeur : AHA-BUCH GmbH, Einbeck, AllemagneAHA-BUCH GmbH

    Vendeur avec une évaluation de 5 étoiles
    Contacter le vendeur

    Etat: Neuf

    EUR 346,30

    EUR 42,83 expédition 
    Expédition depuis Allemagne vers Etats-Unis

    Quantité disponible : 2 disponibles

    Buch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Gene and cell therapy is entering a new phase, one where artificial intelligence is bringing precision and predictability to editing systems that were once largely trial-and-error. From CRISPR-Cas genome editing to emerging techniques like epigenome modulation and mitochondrial genome correction, machine learning and deep learning are increasingly guiding how these tools are designed and scaled. AI is helping minimize off-target effects, improve manufacturing predictability, and build in the kind of explainability and bias mitigation that safety and regulatory approval demand. As these technologies move closer to widespread clinical use, the field needs a framework that ties computational innovation directly to therapeutic application, rather than treating AI and biomedicine as separate conversations. This convergence of computational innovation and biological engineering marks one of the most consequential shifts in modern therapeutic science. AI-Driven Innovations in Genome, Epigenome, and Mitochondrial Therapies provides state-of-the-art, data-driven methodologies for designing, optimizing, and validating safer, more precise, and scalable gene and cell therapies. By connecting concrete biomedical applications with benchmarked computational pipelines and structured frameworks for transparent, accountable AI governance, this book equips researchers and practitioners to navigate discovery, preclinical validation, clinical translation, and lifecycle risk management. Covering topics such as genome-enabled precision wound care, mitochondrial mutation detection, and mitochondrial editing, this book is an excellent academic resource for graduate and doctoral students, biomedical researchers, AI and machine learning specialists, bioinformaticians, regulatory affairs professionals, policymakers, and more.…